Research Article
Association of Serum Uric Acid Concentration and Its Change with Cardiovascular Death and All-Cause Mortality
Table 2
Characteristics of alive and dead patients.
| Status | Alive | Dead | value |
| Number of patients | | | | Range of uric acid variability values (%) | | | 0.193 | Age (year) | | | <0.001 | Male | 124 (59.3%) | 71 (61.2%) | 0.741 | Female | 85 (40.7%) | 45 (38.8%) | Tunneled cuffed catheter (%) | 50 (23.9%) | 39 (33.6%) | 0.06 | AvF (%) | 159 (76.1%) | 77 (66.4%) | Hypertension (%) | 207 (99.0%) | 115 (99.1%) | 0.932 | Hemoglobin (g/L) | | | 0.132 | Phosphorus (mmol/L) | | | <0.001 | Calcium (mmol/L) | | | 0.904 | PTH (μg/L) | | | <0.001 | Albumin (g/L) | | | <0.001 | Uric acid (μmol/L) | | | <0.001 | Primary renal disease () | | | 0.003 | Hypertensive kidney lesion | 16 (7.7%) | 10 (8.6%) | | ANCA | 1 (0.5%) | 2 (1.7%) | | Diabetes | 79 (37.8%) | 68 (58.6%) | | Glomerulonephritis | 90 (43.1%) | 27 (23.3%) | | Drug-induced kidney damage | 3 (1.4%) | 0 (0.0%) | | Polycystic kidney | 7 (3.3%) | 4 (3.4%) | | Renal allograft dysfunction | 6 (2.9%) | 0 (0.0%) | | Lupus nephritis | 2 (1.0%) | 0 (0.0%) | | Obstructive nephropathy | 5 (2.4%) | 5 (4.3%) | |
|
|
AvF = arteriovenous fistula; PTH = parathyroid hormone; = number; ANCA = antineutrophil cytoplasmic antibodies. |